
<!DOCTYPE html><HTML><HEAD>
<META HTTP-EQUIV="X-UA-Compatible" CONTENT="IE=EDGE" />
<LINK rel="stylesheet" href="CRStyleSheet.css"></LINK>
</HEAD>
<body id="theBody">
<div id="oContextHTML" style="display: none;"></div>
<div id="oContent">
<table class="Header2"><tbody><tr><td>HISTOLOGIC_TYPE_2</td></tr></tbody></table>
<table class="KeyValue"><tbody>
<tr>
<td width="10%" align="left" class="T1Head">Description: </td>
<td class="T1Value" colspan="5">
<table class="SubList"><tbody>
<tr>
<td class="T1Value" style="white-space: normal;">Stores data for College of American Pathologists (CAP) form field Second Histologic Type.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Primary Key</td></tr></tbody></table>
<table class="List"><tbody>
<tr>
<th>Column Name</th>
<th>Ordinal Position</th>
<th width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>RESULT_ID</td>
<td>1</td>
<td width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>LINE</td>
<td>2</td>
<td width="90%"/>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Column Information</td></tr></tbody></table>
<table class="SubList List"><tbody>
<tr>
<th style="min-width: 0px;"/>
<th>Name</th>
<th>Type</th>
<th>Discontinued?</th>
<th width="90%"/>
</tr>
<tr>
<td class="T1Head" style="padding: 5px;">1</td>
<td class="T1Head" style="padding-right: 12px;">RESULT_ID</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> The unique identifier for the result record.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">2</td>
<td class="T1Head" style="padding-right: 12px;">LINE</td>
<td class="T1Head" style="padding-right: 12px;">INTEGER</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> The line number for the information associated with this record. Multiple pieces of information can be associated with this record.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">3</td>
<td class="T1Head" style="padding-right: 12px;">HIST_TYPE_2_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Histologic Type for second tumor.</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adrenal cortical carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma (not otherwise characterized)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Signet-ring cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenosquamous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Paget disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous (colloid) adenocarcinoma (greater than 50% mucinous)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Signet-ring cell carcinoma (greater than 50% signet-ring cells)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Goblet cell carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell neuroendocrine carccinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Biliary cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cholangiocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined hepatocellular and cholangiocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bile duct cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloproliferative Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid and Lymphoid Neoplasms w/ Eosinophilia and Abnormalities PDGFRA/PDGFRB /FGFR1</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic / Myeloproliferative Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myelodysplastic Syndromes</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute Myeloid Leukemia With Myelodysplasia-Related Changes</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Therapy-related Myeloid Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute Myeloid Leukemia, Not Otherwise Specified (NOS)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myeloid Proliferations Related to Down Syndrome</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acute Leukemias of Ambiguous Lineage</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other Myeloid Leukemias</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Precursor Lymphoid Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mature B-cell Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mature T- and NK-cell Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin Lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Histiocytic and Dendritic Cell Neoplasms</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Post-transplant Lymphoproliferative Disorders (PTLD)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Astrocytic Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligodendroglial Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oligoastrocytic Tumors (mixed glioma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ependymal Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choroid Plexus Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other Neuroepithelial Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuronal and Mixed Neuronal-Glial Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumors of the Pineal Region</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumors of Cranial and Paraspinal Nerves</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumors of the Meninges / Meningothelial Cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mesenchymal (Nonmeningothelial) Tumors (Note I)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Melanotic Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumors of Uncertain Histogenesis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoma and Hematopoietic Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Germ Cell Tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tumors of the Sellar Region</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ductal carcinoma in situ. Classified as Tis (DCIS) or Tis (Paget)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Medullary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenocarcinoma, not otherwise characterized</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid adenocarcinoma, variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transitional cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma (malignant müllerian mixed tumor)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubal intraepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Angiosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid hemangioendothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant pleomorphic fibrous histiocytoma (MFH) / Undifferentiated pleomorphic sarco</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myxoid fibrosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Leiomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Osteosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Synovial sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Liposarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, epithelial type, fetal pattern (mitotically inactive)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, epithelial type, fetal pattern (mitotically active)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, epithelial type, fetal and embryonal pattern</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, epithelial type, macrotrabecular pattern</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, epithelial type, small cell undifferentiated pattern</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, mixed epithelial and mesenchymal type without teratoid features</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, mixed epithelial and mesenchymal type with teratoid features</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, rhabdoid type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatoblastoma, other</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hepatocellular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fibrolamellar hepatocellular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hodgkin lymphoma, histologic subtype cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Classical Hodgkin lymphoma, histologic subtype cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodular lymphocyte predominant Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodular sclerosis classical Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed cellularity classical Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphocyte-rich classical Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphocyte-depleted classical Hodgkin lymphoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Multiocular clear cell renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary renal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Chromophobe renal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma of the collecting ducts of Bellini</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renal medullary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Translocation carcinoma (Xp11 or others)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma associated with neuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous tubular and spindle cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubulocystic renal cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Renal cell carcinoma, unclassified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, conventional</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acantholytic squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basaloid squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary squamous cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell squamous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Verrucous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Giant cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepithelioma-like carcinoma (non-nasopharyngeal)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined (or composite) small cell carcinoma, neuroendocrine type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucosal malignant melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenoid cystic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucoepidermoid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma cuniculatum</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, not otherwise specified (NOS) (Minor Salivary glands)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepithelial carcinoma (non-nasopharyngeal)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinic cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, not otherwise specified (NOS)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basal cell adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, not otherwise specified (NOS) (Non-Salivary Gland Type)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelial-myoepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenocarcinoma (colloid carcinoma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Myoepithelial carcinoma (malignant myoepithelioma)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Oncocytic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Polymorphous low-grade adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Salivary duct carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;"> Combined (or composite) small cell carcinoma, neuroendocrine type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Non-small cell carcinoma, subtype cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined small cell carcinoma (small cell carcinoma and non-small cell component)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, papillary variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, clear cell variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, small cell variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, basaloid variant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, mixed subtype</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bronchioloalveolar carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bronchioloalveolar carcinoma, nonmucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bronchioloalveolar carcinoma, mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Bronchioloalveolar carcinoma, mixed nonmucinous and mucinous</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Solid adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Fetal adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous (colloid) adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Signet ring adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell neuroendocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Combined large cell neuroendocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Basaloid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepithelioma-like carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Large cell carcinoma with rhabdoid phenotype</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sarcomatoid carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pleomorphic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Pulmonary blastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Typical carcinoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Atypical carcinoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma ex pleomorphic adenoma (malignant mixed tumor)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma (true malignant mixed tumor)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low-grade cribriform cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lymphoepithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Metastasizing pleomorphic adenoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sebaceous adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sialoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Small cell (neuroendocrine) carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, primary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated carcinoma, large cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid mesothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sarcomatoid mesothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Biphasic mesothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic mesothelioma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanoma, not otherwise classified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Superficial spreading melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nodular melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Lentigo maligna melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acral-lentiginous melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Desmoplastic and / or desmoplastic neurotropic melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanoma arising from blue nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanoma arising in a giant congenital nevus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Melanoma of childhood</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nevoid melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Persistent melanoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sinonasal undifferentiated carcinoma (SNUC)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Non-intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Neuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioneuroblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ganglioneuroma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous, borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous, carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous, borderline tumor, intestinal type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous, borderline tumor, endocervical type (seromucinous type)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous, carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Endometrioid, carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell, carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transitional cell borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Transitional cell, carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Brenner tumor, malignant type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed epithelial borderline tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed epithelial carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinosarcoma (Malignant mullerian mixed tumor)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Granulosa cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other sex cord-stromal tumor </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant germ cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Well-differentiated endocrine neoplasm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Poorly differentiated endocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ductal adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous noncystic carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated (anaplastic) carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated carcinoma with osteoclast-like giant cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed ductal-endocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous cystic neoplasm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intraductal papillary-mucinous carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Acinar cell cystadenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed acinar-endocrine carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant mesothelioma, epithelioid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant mesothelioma, sarcomatoid (spindle cell)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant mesothelioma, biphasic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant mesothelioma, other</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Serous borderline tumor (of low malignant potential)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other malignant tumor of Mullerian type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Keratinizing squamous cell carcinoma (formerly WHO-1)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nonkeratinizing carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Nasopharyngeal papillary adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma (acinar, not otherwise specified)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Prostatic duct adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated carcinoma, not otherwise specified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial (transitional cell) carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial (transitional cell) carcinoma with squamous differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial (transitional cell) carcinoma with glandular differentiation</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Urothelial (transitional cell) carcinoma with variant histology</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, typical</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Squamous cell carcinoma, variant histology</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, typical</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, variant histology</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal, botryoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal, spindle cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal, not otherwise specified (NOS)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Alveolar</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed embryonal and alveolar rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdoid rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sclerosing rhabdomyosarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Undifferentiated sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ectomesenchymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mucinous adenocarcinoma (greater than 50% mucinous)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed carcinoid-adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Adenocarcinoma, diffuse type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Tubular adenocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Intratubular germ cell neoplasia, unclassified only</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seminoma, classic type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seminoma with associated scar (Note D)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Seminoma with syncytiotrophoblastic cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed germ cell tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Embryonal carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Yolk sac tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choriocarcinoma, biphasic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choriocarcinoma, monophasic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Placental site trophoblastic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Teratoma with a secondary somatic-type malignant component</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monodermal teratoma, carcinoid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monodermal teratoma, primitive neuroectodermal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Monodermal teratoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spermatocytic seminoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spermatocytic seminoma with a sarcomatous component</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed germ cell-sex cord-stromal tumor, gonadoblastoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Mixed germ cell-sex cord-stromal tumor, others</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Testicular scar (Note D)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Sex cord-stromal tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant neoplasm, type cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cystic trophoblastic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Type A thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Type AB thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Type B1 thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Type B2 thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Type B3 thymoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymoma, Other</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Thymic carcinoma, Other</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Papillary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Follicular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Poorly differentiated thyroid carcinomas, including insular carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hydatidiform mole, complete</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hydatidiform mole, partial</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Hydatidiform mole, invasive</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Choriocarcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid trophoblastic tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Spindle cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Epithelioid cell type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Necrotic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Glandular tumors</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Wilms tumor, favorable histology</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Wilms tumor, focal anaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Wilms tumor, diffuse anaplasia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Congenital mesoblastic nephroma, classical</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Congenital mesoblastic nephroma, cellular</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Congenital mesoblastic nephroma, mixed</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Clear cell sarcoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdoid tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant neoplasm, type indeterminate</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Balloon cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Retinoblastoma, NOS</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant trophoblastic tumor, type cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other Carcinoma of minor salivary gland</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other Adenocarcinoma, Non-Salivary Gland Type</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other Neuroendocrine Carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cannot be assessed</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Indeterminate</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Rhabdosarcoma, subtype indeterminate</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Malignant tumor, type cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, type cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Carcinoma, not otherwise specified</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
</tbody></table>
<br/><br/>
<br/><br/>
</div></body></HTML>